Related Experiment Video
Updated: May 8, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Update on the classification and treatment of localized scleroderma.
1Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Universidad Autónoma de Barcelona, Barcelona, Spain.
Actas Dermo-Sifiliograficas
|August 17, 2013
Summary
Morphea, a localized scleroderma, causes skin and tissue hardening with unclear subtypes. Effective universal treatment is lacking, necessitating accurate disease assessment for management.
Area of Science:
- Dermatology
- Rheumatology
- Immunology
Background:
- Morphea, or localized scleroderma, is an inflammatory condition causing skin and subcutaneous tissue sclerosis.
- It presents with diverse subtypes based on clinical features and affected tissue structures.
- Accurate classification is challenging due to overlapping features between subtypes.
Purpose of the Study:
- To review the classification, clinical presentation, and management challenges of morphea.
- To highlight the main subtypes: plaque, linear, generalized, and pansclerotic morphea.
- To emphasize the importance of accurate disease assessment for treatment planning.
Main Methods:
- Review of existing literature on morphea classification and clinical characteristics.
- Analysis of diagnostic criteria and epidemiological data.
- Synthesis of current understanding of disease progression and complications.
Main Results:
- Morphea subtypes include plaque, linear, generalized, and pansclerotic forms.
- While generally not systemic, morphea can cause significant morbidity.
- Neurological and ocular complications may arise with head involvement.
Conclusions:
- Morphea classification remains complex due to blurred boundaries and overlapping entities.
- Effective, universal treatments are not established.
- Precise assessment of disease extent and severity is crucial for guiding treatment decisions.
Keywords:
Atrofodermia de Pasini y PieriniAtrophoderma of Pasini and PieriniDeep morpheaEosinophilic fasciitisFascitis eosinofílicaHemiatrofia facial progresivaLichen sclerosus et atrophicusLiquen escleroso y atróficoMorfea en coup de sabreMorfea profundaMorphea en coup de sabreProgressive facial hemiatrophy
Related Concept Videos
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...